Literature DB >> 21801465

Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.

Y H Leung1, W L Lim, M H Wong, S K Chuang.   

Abstract

During the early phase of the influenza pandemic in 2009, all cases of laboratory-confirmed pandemic (H1N1) 2009 (pH1N1) infection required compulsory isolation in hospital. These cases were offered oseltamivir treatment and only allowed to be discharged from the hospital when three consecutive respiratory specimens were negative for the virus by reverse transcription-polymerase chain reaction (RT-PCR). We reviewed the case records of these patients to assess the viral shedding kinetics of the pH1N1 virus. We defined viral shedding duration as the interval from illness onset date to the date of collection of the last positive specimen from the patients. Fifty-six patients were included in the study, of whom 96% received oseltamivir. The median viral shedding duration of pH1N1 virus by viral culture and RT-PCR were 3 days and 4 days, respectively. Patients who started oseltamivir treatment >48 h after onset had a significantly longer median viral shedding duration by viral culture than those who started treatment within 48 h of onset (4 days vs. 2 days, P=0·014).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801465     DOI: 10.1017/S0950268811001415

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014.

Authors:  Claire von Mollendorf; Orienka Hellferscee; Ziyaad Valley-Omar; Florette K Treurnicht; Sibongile Walaza; Neil A Martinson; Limakatso Lebina; Katlego Mothlaoleng; Gethwana Mahlase; Ebrahim Variava; Adam L Cohen; Marietjie Venter; Cheryl Cohen; Stefano Tempia
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 5.226

2.  Development of an RNA Strand-Specific Hybridization Assay To Differentiate Replicating versus Nonreplicating Influenza A Viruses.

Authors:  Genyan Yang; Erin N Hodges; Jörn Winter; Natosha Zanders; Svetlana Shcherbik; Tatiana Bousse; Janna R Murray; A K M Muraduzzaman; Mahbubur Rahman; A S M Alamgir; Meerjady Sabrina Flora; Lenee Blanton; John R Barnes; David E Wentworth; C Todd Davis
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

3.  Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households.

Authors:  Cuiling Xu; Kwok-Hung Chan; Tim K Tsang; Vicky J Fang; Rita O P Fung; Dennis K M Ip; Simon Cauchemez; Gabriel M Leung; J S Malik Peiris; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2015-09-22       Impact factor: 4.897

4.  Viral load dynamics in adult patients with A(H1N1)pdm09 influenza.

Authors:  J Y Noh; J Y Song; S Y Hwang; W S Choi; J Y Heo; H J Cheong; W J Kim
Journal:  Epidemiol Infect       Date:  2013-07-18       Impact factor: 4.434

5.  Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010-2011.

Authors:  Pragna Patel; Timothy Bush; E Milu Kojic; Edgar T Overton; Keith Henry; Nur Önen; Frank Rhame; Lois Conley; John T Brooks; Alicia Fry
Journal:  AIDS Res Hum Retroviruses       Date:  2016-06-13       Impact factor: 2.205

6.  Possible explanations for why some countries were harder hit by the pandemic influenza virus in 2009 - a global mortality impact modeling study.

Authors:  Kathleen F Morales; John Paget; Peter Spreeuwenberg
Journal:  BMC Infect Dis       Date:  2017-09-25       Impact factor: 3.090

Review 7.  The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong.

Authors:  Peng Wu; Benjamin J Cowling; Joseph T Wu; Eric H Y Lau; Dennis K M Ip; Hiroshi Nishiura
Journal:  Influenza Other Respir Viruses       Date:  2012-08-09       Impact factor: 4.380

Review 8.  Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age.

Authors:  James E Fielding; Heath A Kelly; Geoffry N Mercer; Kathryn Glass
Journal:  Influenza Other Respir Viruses       Date:  2013-12-02       Impact factor: 4.380

9.  Inhibitory Potentiality of Secondary Metabolites Extracted from Marine Fungus Target on Avian Influenza Virus-A Subtype H5N8 (Neuraminidase) and H5N1 (Nucleoprotein): A Rational Virtual Screening.

Authors:  Md Mukthar Mia; Mahamudul Hasan; Muhammad Milon Miah; Mohammad Abdus Shahid Hossain; Senior Executive Veterinary Technical Services Md Shariful Islam; Veterinary Consultant Public Health Rifat Noor Shanta
Journal:  Vet Anim Sci       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.